Unknown PHASE3 INTERVENTIONAL 3-arm NCT00655421

Oral Cancer Screening in Mumbai, India by Primary Health Care Workers

Comparing the Test Characteristics of Three Oral Cancer Screening Techniques:1)Unaided Visual Examination 2)VelScope Examination and 3)Toluidine Blue Application, by Trained Primary Health Care Workers in Mumbai, India.

Sponsor: American Cancer Society, Inc.

Conditions Oral Cancer Precancerous Conditions

Interventions Toluidine Blue Assisted Oral Examination Unaided Visual Inspection VelScope

Updated 5 times since 2017 Last updated: Jul 2, 2009 Started: Apr 30, 2008 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00655421, this PHASE3 trial focuses on Oral Cancer and Precancerous Conditions and remains ongoing. Sponsored by American Cancer Society, Inc., it has been updated 5 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Cancer Society, Inc.
Emory University
Tata Memorial Hospital

Data source: Tata Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India